The Jacobs School of Medicine and Biomedical Sciences is among 72 sites nationwide that are recruiting patients for a 12-week, randomized, placebo-controlled drug trial for the first treatment designed to benefit patients with mild-to-moderate Lewy body dementia (LBD).
Richard M. Gronostajski, PhD, professor of biochemistry, says the unconfirmed claims of genetically modified humans being developed in China is a source of concern for biologists and bioethicists around the world.
Jun-Xu Li, MD, PhD, associate professor of pharmacology and toxicology, is being recognized by the American Society for Pharmacology and Experimental Therapeutics (ASPET) with the inaugural JH Woods Early Career Award in Behavioral Pharmacology.
A new approach to Alzheimer’s disease (AD) that may eventually make it possible to reverse memory loss is outlined in newly published research led by Zhen Yan, PhD, SUNY Distinguished Professor of physiology and biophysics.
Research by Gil I. Wolfe, MD, UB Distinguished Professor and Irvin and Rosemary Smith Chair of the Department of Neurology, shows that surgery to remove the thymus gland in patients with myasthenia gravis (MG) provides significant clinical benefits for as long as five years after the procedure.
Joshua H. Gordon, a student in the MD-PhD Program, is lead author of a study showing that postmenopausal women who have experienced loss of all teeth are at higher risk of developing high blood pressure.
Researchers in the Department of Emergency Medicine are the first to clinically assess and validate a rule regarding the length of observation time necessary before opioid overdose patients can be safely discharged from an emergency department (ED).